Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy

N. M. Chapman, K. S. Kim

Research output: Chapter in Book/Report/Conference proceedingChapter

93 Citations (Scopus)

Abstract

Enteroviral infection of the heart has been noted in a significant proportion of cases of myocarditis and dilated cardiomyopathy. The presence of enterovirus RNA at stages of disease after acute infection and correlation of enterovirus replication with worse clinical outcome suggests continued replication of the virus is involved in the progression of the disease. This finding is mirrored by the murine model of coxsackievirus B3 myocarditis, in which virus persists through the evolution of the virus to a terminally deleted defective form which persists in the myocardium. Studies of the mechanism of induction of myocarditis by coxsackievirus B3 require assessment of the effects of alterations of the immune response upon virus persistence in this form. As expression of viral proteins in the heart have been shown to generate significant impairment of cardiomyocyte function and promote generation of dilated cardiomyopathy, the role of virus persistence is likely to include direct effects of viral replication as well as induction of inflammation in the heart. Factors that control the extent of cardiac infection with terminally deleted enteroviruses and the relative roles of continued immune response of the virus vs viral modification of cardiac function need to be measured to find effective therapies for the human disease.

Original languageEnglish (US)
Title of host publicationGroup B Coxsackieviruses
EditorsSteven Tracy, Kristen Drescher, Steven Oberste
Pages275-292
Number of pages18
DOIs
StatePublished - Dec 1 2008

Publication series

NameCurrent Topics in Microbiology and Immunology
Volume323
ISSN (Print)0070-217X

Fingerprint

Coxsackievirus Infections
Enterovirus
Myocarditis
Dilated Cardiomyopathy
Viruses
Enterovirus Infections
Viral Proteins
Acute Disease
Virus Replication
Infection
Cardiac Myocytes
Disease Progression
Myocardium
RNA
Inflammation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Microbiology
  • Immunology
  • Microbiology (medical)

Cite this

Chapman, N. M., & Kim, K. S. (2008). Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. In S. Tracy, K. Drescher, & S. Oberste (Eds.), Group B Coxsackieviruses (pp. 275-292). (Current Topics in Microbiology and Immunology; Vol. 323). https://doi.org/10.1007/978-3-540-75546-3-13

Persistent coxsackievirus infection : Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. / Chapman, N. M.; Kim, K. S.

Group B Coxsackieviruses. ed. / Steven Tracy; Kristen Drescher; Steven Oberste. 2008. p. 275-292 (Current Topics in Microbiology and Immunology; Vol. 323).

Research output: Chapter in Book/Report/Conference proceedingChapter

Chapman, NM & Kim, KS 2008, Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. in S Tracy, K Drescher & S Oberste (eds), Group B Coxsackieviruses. Current Topics in Microbiology and Immunology, vol. 323, pp. 275-292. https://doi.org/10.1007/978-3-540-75546-3-13
Chapman NM, Kim KS. Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. In Tracy S, Drescher K, Oberste S, editors, Group B Coxsackieviruses. 2008. p. 275-292. (Current Topics in Microbiology and Immunology). https://doi.org/10.1007/978-3-540-75546-3-13
Chapman, N. M. ; Kim, K. S. / Persistent coxsackievirus infection : Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Group B Coxsackieviruses. editor / Steven Tracy ; Kristen Drescher ; Steven Oberste. 2008. pp. 275-292 (Current Topics in Microbiology and Immunology).
@inbook{2cad1d3b4bd74f9680bbad9d2717dd6f,
title = "Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy",
abstract = "Enteroviral infection of the heart has been noted in a significant proportion of cases of myocarditis and dilated cardiomyopathy. The presence of enterovirus RNA at stages of disease after acute infection and correlation of enterovirus replication with worse clinical outcome suggests continued replication of the virus is involved in the progression of the disease. This finding is mirrored by the murine model of coxsackievirus B3 myocarditis, in which virus persists through the evolution of the virus to a terminally deleted defective form which persists in the myocardium. Studies of the mechanism of induction of myocarditis by coxsackievirus B3 require assessment of the effects of alterations of the immune response upon virus persistence in this form. As expression of viral proteins in the heart have been shown to generate significant impairment of cardiomyocyte function and promote generation of dilated cardiomyopathy, the role of virus persistence is likely to include direct effects of viral replication as well as induction of inflammation in the heart. Factors that control the extent of cardiac infection with terminally deleted enteroviruses and the relative roles of continued immune response of the virus vs viral modification of cardiac function need to be measured to find effective therapies for the human disease.",
author = "Chapman, {N. M.} and Kim, {K. S.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-3-540-75546-3-13",
language = "English (US)",
isbn = "9783540755456",
series = "Current Topics in Microbiology and Immunology",
pages = "275--292",
editor = "Steven Tracy and Kristen Drescher and Steven Oberste",
booktitle = "Group B Coxsackieviruses",

}

TY - CHAP

T1 - Persistent coxsackievirus infection

T2 - Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy

AU - Chapman, N. M.

AU - Kim, K. S.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Enteroviral infection of the heart has been noted in a significant proportion of cases of myocarditis and dilated cardiomyopathy. The presence of enterovirus RNA at stages of disease after acute infection and correlation of enterovirus replication with worse clinical outcome suggests continued replication of the virus is involved in the progression of the disease. This finding is mirrored by the murine model of coxsackievirus B3 myocarditis, in which virus persists through the evolution of the virus to a terminally deleted defective form which persists in the myocardium. Studies of the mechanism of induction of myocarditis by coxsackievirus B3 require assessment of the effects of alterations of the immune response upon virus persistence in this form. As expression of viral proteins in the heart have been shown to generate significant impairment of cardiomyocyte function and promote generation of dilated cardiomyopathy, the role of virus persistence is likely to include direct effects of viral replication as well as induction of inflammation in the heart. Factors that control the extent of cardiac infection with terminally deleted enteroviruses and the relative roles of continued immune response of the virus vs viral modification of cardiac function need to be measured to find effective therapies for the human disease.

AB - Enteroviral infection of the heart has been noted in a significant proportion of cases of myocarditis and dilated cardiomyopathy. The presence of enterovirus RNA at stages of disease after acute infection and correlation of enterovirus replication with worse clinical outcome suggests continued replication of the virus is involved in the progression of the disease. This finding is mirrored by the murine model of coxsackievirus B3 myocarditis, in which virus persists through the evolution of the virus to a terminally deleted defective form which persists in the myocardium. Studies of the mechanism of induction of myocarditis by coxsackievirus B3 require assessment of the effects of alterations of the immune response upon virus persistence in this form. As expression of viral proteins in the heart have been shown to generate significant impairment of cardiomyocyte function and promote generation of dilated cardiomyopathy, the role of virus persistence is likely to include direct effects of viral replication as well as induction of inflammation in the heart. Factors that control the extent of cardiac infection with terminally deleted enteroviruses and the relative roles of continued immune response of the virus vs viral modification of cardiac function need to be measured to find effective therapies for the human disease.

UR - http://www.scopus.com/inward/record.url?scp=43349095303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43349095303&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-75546-3-13

DO - 10.1007/978-3-540-75546-3-13

M3 - Chapter

C2 - 18357775

AN - SCOPUS:43349095303

SN - 9783540755456

T3 - Current Topics in Microbiology and Immunology

SP - 275

EP - 292

BT - Group B Coxsackieviruses

A2 - Tracy, Steven

A2 - Drescher, Kristen

A2 - Oberste, Steven

ER -